Adaptive Biotechnologies develops an immune medicine platform for diagnosing and treating diseases, including cancer, autoimmune conditions, and infectious diseases. Its products include immunoSEQ, T-Detect COVID, clonoSEQ, and immunoSEQ T-MAP COVID. The company collaborates with Genentech and Microsoft to develop therapies and diagnostic tests. Adaptive Biotechnologies was founded in 2009 and is headquartered in Seattle, Washington.
Kazi Maalum
Makampuni Yanayohusiana
Rasilimali Zingine